P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays

Ítems similars

• P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific
  per: Wieczorek, L, et al.
  Publicat: (2009)
• P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
  per: Matyas, GR, et al.
  Publicat: (2009)
• The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization.
  per: Bruce K Brown, et al.
  Publicat: (2012-01-01)
• The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization
  per: Brown, Bruce K., et al.
  Publicat: (2012)
• P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
  per: Chenine, A, et al.
  Publicat: (2009)